Dr Lalchandani Labs Limited (BOM:541299)
India flag India · Delayed Price · Currency is INR
7.77
+0.01 (0.13%)
At close: Jul 31, 2026

Dr Lalchandani Labs Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
41.8641.8644.5448.150.4112.79
Revenue Growth
-4.42%-6.02%-7.39%-4.58%-55.31%15.32%
Gross Profit
17.0817.0826.4216.7823.3966.56
Operating Income
-4.98-4.983.6-3.92-5.7318.84
Net Income
0.640.644.176.18-15.639.33
Earnings Per Share
0.070.070.961.43-3.612.15
EPS Growth
-93.40%-92.71%-32.87%---7.72%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
41.4141.4132.9722.9232.1235.33
Total Debt
20.6420.6440.6734.7864.0551.44
Net Cash (Debt)
20.7720.77-7.7-11.86-31.92-16.11
Net Cash Growth
------
Net Cash Per Share
2.292.29-1.77-2.75-7.37-3.71

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-7.65-7.653.67-2.180.0120.06
Capital Expenditures
-3.3-3.3-1.55-1.15-3.05-10.95
Free Cash Flow
-10.95-10.952.12-3.33-3.049.1
Free Cash Flow Growth
-----1.10%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
40.81%40.81%59.33%34.89%46.41%59.01%
Operating Margin
-11.89%-11.89%8.09%-8.14%-11.36%16.70%
Pretax Margin
2.33%2.33%9.03%12.84%-31.01%11.41%
Profit Margin
1.52%1.52%9.37%12.84%-31.01%8.28%
FCF Margin
-26.15%-26.15%4.77%-6.92%-6.02%8.07%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
111.00201.4410.6211.02-15.32
P/FCF Ratio
--20.85--15.71
PS Ratio
1.603.060.991.422.441.27